Navigation Links
Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients
Date:6/8/2009

Pre-heparinization Limits Clot Retention and Decreases Residual Clot Volume

SAN FRANCISCO, June 8 /PRNewswire/ -- MAQUET Cardiovascular LLC announced today that data presented at the annual meeting of the International Society for Minimally Invasive Cardiothoracic Surgery show that administration of a heparin bolus with doses as low as 2500U prior to endoscopic vein harvest (EVH) was associated with improved acute saphenous vein (SV) graft patency in patients undergoing off-pump coronary artery bypass (OPCAB). Pre-heparinization was also linked to a significant reduction in the incidence and volume of residual clot strands within the vein.

In EVH, a small incision is made in the leg, through which an endoscope is passed and the vein harvested for coronary artery bypass graft (CABG) procedures. This method reduces patient discomfort and scarring.

EVH also significantly reduces wound complications and hastens recovery time compared to traditional techniques that involve a long incision to expose the entire length of the vein.

"In our experience, the impact of pre-heparinization on surgical bleeding is minimal, making it a promising strategy that may improve patient outcomes with minimally invasive vein harvesting," said lead investigator Robert Poston, M.D., Chief, Division of Cardiac Surgery, Boston University.

The prospective study examined acute patency rates in 460 patients that underwent OPCAB using veins acquired through EVH, comparing patients receiving no heparin prior to harvest (n=306) to those who received one of three doses of heparin prior to the procedure (n=181). A subset of the most recent 110 patients underwent catheter-based infrared imaging (OCT) of the full tract of harvested SV in order to measure residual clot within the vein. Overall, vein graft patency was 98.9 percent in patients treated with heparin compared to 95.2 percent in
'/>"/>

SOURCE MAQUET Cardiovascular LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Interface Biologics Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
2. ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
3. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
4. Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment
5. Alimera Sciences Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout
6. Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis
7. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
8. RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
9. ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments
10. RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
11. REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire-USNewswire/--RemediumTechnologiesInc.,aco...rebleeding,wonfirstprizeand$10,000intheMostPromisi...2009,companyofficialsannouncetoday. ,, Selected...steampitchedtheirinventionattheGSCSecuritySummitco...edium( www.remediumtechnologies.com )isdevelopinga...
(Date:11/25/2009)...PRNewswire/--RegadoBiosciences,aprivatelyheldcompa...hactivecontrolagents,announcedthatDavidMazzo,PhD,C...stAnnualHealthCareConferenceattheNewYorkPalaceHote...1:10pm(EST)onTuesday,December1andwillincludeanover...elopmentprogram,theanticoagulantsystem,REG1.Thehea...
(Date:11/25/2009).../--Reportlinker.comannouncesthatanewmarketresearch...esDentalDevicesMarketAnalysisandForecaststo2015 ,...States-Dental-Devices-Market-Analysis-and-Forecast...ketAnalysisandForecaststo2015 ,, Summary ,...ionanddatarelatingtotheUSdentaldevicesmarket.Itals...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Gersten Savage Expands IP Practice With Partner Jason Lief 58308 1Gersten Savage Expands IP Practice With Partner Jason Lief 58308 2Oncolytics Biotech 28R 29 Inc Announces Reovirus and Cisplatin Research Supports U S Phase 2 Metastatic Melanoma Trial 14269 1Oncolytics Biotech 28R 29 Inc Announces Reovirus and Cisplatin Research Supports U S Phase 2 Metastatic Melanoma Trial 14269 2Michigan Life Science and Innovation Center Opens in Former Pfizer Facility 5064 1Michigan Life Science and Innovation Center Opens in Former Pfizer Facility 5064 2Michigan Life Science and Innovation Center Opens in Former Pfizer Facility 5064 3
.... 3 Breast-specific gamma imaging,(BSGI) is effec...ograms or by,clinical exam, according to a study p...ogical Society of North America (RSNA). , "B...st cancer-invasive,lobular carcinoma," said lead a... and director of the Breast Imaging and Interventi...
...., Dec. 2 Micromet, Inc. (Nasdaq: MITI ), a bio...ry antibodies for the treatment of cancer, inflamm...t it has entered into an agreement expanding its C...gsbridge Capital Limited, a private investment gro... has committed to provide up to $75 million of cap...
Other Medicine Technology:New Breast Imaging Technology Targets Hard-to-Detect Cancers 2New Breast Imaging Technology Targets Hard-to-Detect Cancers 3Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6
(Date:11/27/2009)...UILLY-SUR-SEINE,France,Nov.27/PRNewswire/--TeamGar...teamdedicatedtoethicalsportinganddevelopingthenext...illbecomeTeamGarmin-TransitionswiththeadditionofTr...Opticalistheworld,sleadingmanufacturerofadaptiveey...yinthewidestselectionofspectaclelensessuchasTransi...
(Date:11/27/2009)...tes to bring unprecedented medical, economic burde...HealthDay News) -- The number of people with diabe...r the next 25 years, a new study predicts. , Th...lion people with the disease, up from 23.7 million...ng people with diabetes will triple, the study als...
(Date:11/27/2009)... Specialist manufacturers who use m...re saving millions of dollars by bringing in techn... Increasing numbers of pro-active medical manufact...the concept stage of their projects, ensuring that...gn processes or potentially outdated technology. ...
(Date:11/26/2009)...ext 25 years, the number of Americans living with ...million in 2009 to 44.1 million in 2034. Over the ...le, rising from $113 billion to $336 billion, even...searchers based at the University of Chicago repor...e number of those with diabetes covered by Medicar...
(Date:11/26/2009)... No more letters from the North Pol...ized text messages from Santa , ...ncrease operational efficiencies at the North Pole...keep children all over the globe informed of his C...Santa’s research department have identified ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
... NCCN names Cold Spring Publishing, LLC, as the ne...e National Comprehensive Cancer Network. Cold Spri... company led by Jack Gentile, founder of PRR, Inc....y(TM). , , FORT WASHINGTON, Pa., Feb. 10 JNCCN ...
...China, Feb. 10 /PRNewswire-Asia-FirstCall/ -- Chin...r ,the Company,) (Nasdaq: CSKI ), a,leading full...-the-counter,drugs in the People,s Republic of Chi...ibution from its recent,acquisitions, the Company ...
...led 2.7 million prescriptions through AZ&Me(TM...el., Feb. 10 AstraZeneca (NYSE: AZN ) announc...s to 440,541 patients in the United States last ye...neca is committed to helping patients who are faci...
...b. 10 HMS (Nasdaq: HMSY ) today announced that ...m Neighborhood Health Providers and Optima Health,... lives to its managed care portfolio. HMS will pro...coverage not previously known for its Medicaid mem...
...ems to reduce the risk of cognitive impairment, de...s) -- Chalk up another endorsement for the so-call...s rich in fruits, vegetables, fish and olive oil, ... -- marked by forgetfulness and difficulty concent...
...Calif., Feb. 10 Firefighter and wife help others ... Veteran firefighter Bryan Russell, from the "OC,"...nnifer found the hero in her life when she met fir...e asks, "Do you know any single people?" In Jenn a...
Other Medicine News:Health News:JNCCN Names New Publishing Company 2Health News:JNCCN Names New Publishing Company 3Health News:China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update 2Health News:China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update 3Health News:AstraZeneca Helped More Than 440,000 Patients Save $612 Million on Medicines in 2008 2Health News:HMS Awarded New Contracts for Managed Care Services 2Health News:Mediterranean Diet Aids the Aging Brain: Study 2Health News:Mediterranean Diet Aids the Aging Brain: Study 3Health News:Heroes Find Love, Love Finds Heroes 2
Urocare® Latex Urinary Leg Bag - Short-Wide
Urocare® Latex Urinary Leg Bag - Large
Medtronic Resting Heart™ System
DLP Recirculation Adapter, Y-Type
Medicine Products: